Two scientists with extensive industrial drug discovery and development experience recently joined the Baruch S. Blumberg Institute faculty as professors of Antiviral Drug Discovery and Development.Andrea Cuconati, PhD, a resident of Upper Dublin Township, and Dimitar Gotchev,
[caption id="attachment_19220" align="alignright" width="215"] Governor Kathy Hochul[/caption] New York State officials today announced the team that has been selected to build and launch BioGenesis, a cell and gene therapy center on Long Island, which will include a biotech
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Doylestown, Pa., Aug. 26, 2024 – When Timothy M. Block, PhD, an award-winning virologist and accomplished inventor, launched the
June 5, 2024 Following is noteworthy news about people who work at the Blumberg Institute, which is the research arm of the Hepatitis B Foundation. Nicholas A. Meanwell, Distinguished Professor at the Baruch S. Blumberg Institute, will
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been elected Chair of the Baruch S. Blumberg Institute’s Board of Directors.Located in Doylestown, the Blumberg Institute is a nonprofit organization established by the Hepatitis B
Dr. Kunwar Shailubhai Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD, the pioneer of therapeutic applications of guanylate cyclase-C (GC-C) signaling and an inventor of the widely prescribed medicine Trulance(R), has been awarded a Phase 1
The authors are Blumberg Institute scientists and colleagues at the University of North Carolina. Abstract: Dihydroquinolizinones (DHQs) that inhibit cellular polyadenylating polymerases 5 and 7 (PAPD5 & 7), such as RG7834, have been shown to inhibit both
Through a pilot program aimed at accelerating and supporting life sciences startups in our state, the Pennsylvania Biotechnology Center (PABC)will provide financial support and free lab space to more than a dozen startups at the PABC in Doylestown, its B+labsincubator in Philadelphia and elsewhere in Pennsylvania. The PABC’s new initiative, the Academic Innovation Zone, is managing $5 million through the Commonwealth of
(L-R) Zhengyuan Jiang of the Blumberg Institute, Dr. Patrick Y. S. Lam and Steven Kultgen of Arbutus Biopharma. The Baruch S. Blumberg Institute presented the 2023 Lam Excellence in Medicinal Chemistry Award recently to Steven Kultgen of Arbutus Biopharma,
June 6, 2023 Taimoor Khan, PhD, has joined the Blumberg Institute as a Post Doctoral Research Fellow. He received his doctorate in biology at Shanghai Jiao Tong University in 2021. Prior to joining the Blumberg Institute Dr.
